Dutch Bros declines to raise offer for Salad and Go sites
Dutch Bros declines to raise offer for Salad and Go sites
Profit by knowlytics
Dutch Bros declines to raise offer for Salad and Go sites
Teva announces commitment with Trump administration on Medicaid drug pricing
Tidewater completes acquisition of Wilson Sons Ultratug
YY Group rebrands to YYForce, changes ticker to YFOR
Rakovina Therapeutics closes $597,000 second tranche financing
US stocks declined on Monday as oil prices surged. This jump revived inflation concerns and increased monetary policy tightening expectations. Investors processed hawkish comments from Federal Reserve Chair Kevin Warsh. Despite the day’s losses, major indexes posted monthly gains for August. Financial markets anticipate a potential rate hike at September’s meeting.
The U.S. Securities and Exchange Commission is considering rule changes for shareholder proposals. This shift could reduce investor activist influence and grant new powers to states. Regulations on shareholder proposals may become non-uniform across different states. Investors might face higher share ownership requirements to file resolutions. This change could lead to more votes against corporate…
The landscape of India’s microdrama industry is evolving, shifting from an emphasis on acquiring users to nurturing and monetizing them. Currently, active paying users represent a small fraction of the total users. Analysts predict that the market will converge around a few dominant firms as they navigate global competition and find ways to lower production…
JPMorgan Chase traders are now tactically cautious on US stocks for upcoming weeks. This shift follows Federal Reserve Chairman Kevin Warsh’s hawkish comments on interest rates. Traders cite uncertainty over rate outlook and potential AI stock unwinding as key risks. Despite near-term caution, the broader market backdrop is expected to remain supportive. Economic data and…
Nine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of companies to twenty-six manufacturers. The deals cover medicines for chronic and rare diseases, benefiting Medicaid programs. Sun Pharma will contribute antibiotics to the US Strategic Active Pharmaceutical Ingredients Reserve. These initiatives aim to reduce reliance…